KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Astrana Health (ASTH) Accumulated Depreciation & Amortization (2016 - 2025)

Astrana Health (ASTH) has disclosed Accumulated Depreciation & Amortization for 14 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 117.39% to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Dec 2025, up 117.39% year-over-year, with the annual reading at $5.0 million for FY2025, 117.39% up from the prior year.
  • Accumulated Depreciation & Amortization hit $5.0 million in Q4 2025 for Astrana Health, up from $2.3 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $5.1 million in Q4 2023 to a low of $2.1 million in Q4 2021.
  • Historically, Accumulated Depreciation & Amortization has averaged $3.6 million across 5 years, with a median of $3.7 million in 2022.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: plummeted 54.9% in 2024 and later surged 117.39% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $2.1 million in 2021, then skyrocketed by 76.19% to $3.7 million in 2022, then surged by 37.84% to $5.1 million in 2023, then tumbled by 54.9% to $2.3 million in 2024, then surged by 117.39% to $5.0 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for ASTH at $5.0 million in Q4 2025, $2.3 million in Q4 2024, and $5.1 million in Q4 2023.